Your session is about to expire
← Back to Search
Behavioral Intervention
Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) for Post-Traumatic Stress Disorder
N/A
Waitlist Available
Led By Christal Badour, PhD
Research Sponsored by Christal L Badour
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up average symptom level and change slope from start to end of baseline (4 or 6 weeks) vs. from start to end of the 12-week treatment period
Awards & highlights
Study Summary
This study is evaluating whether a cognitive behavioral therapy can help people with opioid use disorder.
Eligible Conditions
- Post-Traumatic Stress Disorder
- Opioid Use Disorder
- Substance Use Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ average symptom level and change slope from start to end of baseline (4 or 6 weeks) vs. from start to end of the 12-week treatment period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~average symptom level and change slope from start to end of baseline (4 or 6 weeks) vs. from start to end of the 12-week treatment period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
PTSD Checklist for DSM-5 (PCL-5)
Recovery Update Form
Trial Design
2Treatment groups
Experimental Treatment
Group I: 6 week baselineExperimental Treatment1 Intervention
Participants in this arm are randomized to a 6-week baseline period with repeated weekly assessment after the initial intake. This is followed by 12 sessions of weekly individual manualized Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)
Group II: 4 week baselineExperimental Treatment1 Intervention
Participants in this arm are randomized to a 4-week baseline period with repeated weekly assessment after the initial intake. This is followed by 12 sessions of weekly individual manualized Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)
2021
N/A
~30
Find a Location
Who is running the clinical trial?
Christal L BadourLead Sponsor
1 Previous Clinical Trials
12 Total Patients Enrolled
Christal Badour, PhDPrincipal InvestigatorUniversity of Kentucky
1 Previous Clinical Trials
20 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
Kentucky
How old are they?
18 - 65
What site did they apply to?
University of Kentucky
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How responsive is this trial?
Typically responds via
Email
Most responsive sites:
- University of Kentucky: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger